Mannkind Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Mannkind's inventory turnover ratio sequentially decreased to 1.16 in the third quarter 2026, unsurprisingly, as the Mannkind markets continue to deteriorate, and MNKD's faces growing challenges to bring down its inventories. Mannkind's average inventory processing period in the Sep 30 2026 quarter, has increased to 315 days, from 255 days, in the Jun 30 2026 quarter.

Within Healthcare sector 297 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1618 in the second quarter 2026, to 1687.

MNKD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Mannkind Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MNKD Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	79.7 %	55.91 %	70.17 %	26.63 %	1.16 %
Y / Y Cost of Sales Growth	-28.6 %	-9.72 %	-27.52 %	6.42 %	5.93 %
Inventory Turnover Ratio (TTM)	1.16	1.43	1.64	2.04	2.15
MNKD's Total Ranking	# 1687	# 1618	# 1087	# 946	#
Average inventory processing period	315	255	223	179	170
Seq. Inventory Growth	9.12 %	-9.66 %	39.23 %	30.92 %	-5.33 %
Seq. Cost of Sales Growth	-22.18 %	44.61 %	-36.72 %	0.26 %	-1.6 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 83
Healthcare Sector	# 298
Overall Market	# 1687

Inventory Turnover Ratio Statistics
High	Average	Low
5.97	3.07	0.9
(Sep 30 2018)		(Sep 30 2015)

MNKD Company Profile >> Back to MNKD Efficiency Comparisons >> Compare MNKD Inventory Turnover Ratio to its Competitors

Financial Statements
Mannkind's Inventories	$ 48 Millions	Visit MNKD's Balance sheet
Mannkind's Cost of Revenues TTM	$ 51 Millions	Visit MNKD's Income Statement
What are MNKD's Sales?		Visit MNKD's Sales by Segment

Other Inventory Turnover Ratios
Mannkind's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MNKD's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MNKD's Competitors
Inventory Turnover Ratio for MNKD's Suppliers
Inventory Turnover Ratio for MNKD's Customers

You may also want to know
MNKD's Sales Growth Rates	MNKD's Pe Price to earnings ratio	MNKD's Receivables Turnover Ratio	MNKD's Stock Quote
MNKD's Net Income Growth Rates	MNKD's Ps Price to Sales ratio	MNKD's Sales per Employee	MNKD's Asset Turnover Ratio
MNKD's Net Margin	MNKD's Pb Price to Book ratio	MNKD's Financial Strength Ratios	MNKD's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Zai Lab Limited	2.91	$ 200.083 Millions	$ 69 Millions
Amneal Pharmaceuticals Inc	2.90	$ 1,910.255 Millions	$ 658 Millions
Neogen Corporation	2.89	$ 464.774 Millions	$ 161 Millions
Ani Pharmaceuticals Inc	2.87	$ 405.540 Millions	$ 142 Millions
Zevra Therapeutics Inc	2.82	$ 6.736 Millions	$ 2 Millions
Biomerica Inc	2.65	$ 4.297 Millions	$ 2 Millions
Dexcom Inc	2.65	$ 1,867.500 Millions	$ 705 Millions
Dentsply Sirona Inc	2.65	$ 1,769.000 Millions	$ 668 Millions
Avita Medical Inc	2.58	$ 14.936 Millions	$ 6 Millions
Angiodynamics Inc	2.50	$ 142.709 Millions	$ 57 Millions
Abeona Therapeutics Inc	2.46	$ 13.630 Millions	$ 6 Millions
Pro dex Inc	2.45	$ 53.753 Millions	$ 22 Millions
Illumina Inc	2.36	$ 1,458.000 Millions	$ 618 Millions
Tela Bio Inc	2.35	$ 26.999 Millions	$ 11 Millions
Mirum Pharmaceuticals Inc	2.35	$ 59.684 Millions	$ 25 Millions
Aquestive Therapeutics Inc	2.34	$ 16.928 Millions	$ 7 Millions
Lifevantage Corp	2.33	$ 39.482 Millions	$ 17 Millions
Resmed Inc	2.33	$ 2,214.675 Millions	$ 952 Millions
Beta Bionics Inc	2.31	$ 53.285 Millions	$ 23 Millions
Merit Medical Systems Inc	2.25	$ 817.001 Millions	$ 363 Millions
Rigel Pharmaceuticals Inc	2.24	$ 29.869 Millions	$ 13 Millions
Bioventus Inc	2.24	$ 183.856 Millions	$ 82 Millions
Johnson and Johnson	2.17	$ 32,222.000 Millions	$ 14,824 Millions
Orasure Technologies Inc	2.17	$ 66.055 Millions	$ 30 Millions
Standard Biotools Inc	2.16	$ 39.539 Millions	$ 18 Millions
Adc Therapeutics Sa	2.14	$ 5.857 Millions	$ 3 Millions
Icu Medical Inc	2.14	$ 1,304.538 Millions	$ 609 Millions
Glaukos Corp	2.13	$ 131.180 Millions	$ 62 Millions
Halozyme Therapeutics Inc	2.13	$ 319.654 Millions	$ 150 Millions
Organon and Co	2.08	$ 2,859.000 Millions	$ 1,371 Millions

Date modified: 2026-11-09T06:43:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.